Assessment of the reporting quality of observational studies about response to treatment with interferones in patients with RRMS published from 2015 to 2018 using the STROBE statement by Γκοτζαμάνης, Βίκτωρας
                     University of Thessaly                     
School of Health Sciences - Faculty of Medicine 
Master of Science Thesis 
“Assessment of the reporting quality of observational  
Studies about response to treatment with interferons in patients with 
RRMS published from 2015 to 2018  




«Αξιολόγηση της ποιότητας αναφοράς μελετών παρατήρησης σχετικά 
με την ανταπόκριση στη θεραπεία με ιντερφερόνες σε ασθενείς με 
RRMS δημοσιευμένων από το 2015 έως το 2018 με τη χρήση της 
δήλωσης STROBE» 
 
Γκοτζαμάνης Βίκτωρας , Ιατρός 
                                          
Τριμελής Επιτροπή: 
Στεφανίδης Ιωάννης, Καθηγητής Πανεπιστημίου Θεσσαλίας, Τμήμα 
Ιατρικής (επιβλέπων) 
Δοξάνη Χρυσούλα, Επιστημονικός Συνεργάτης Πανεπιστημίου 
Θεσσαλίας 
Ζιντζαράς Ηλίας, Καθηγητής Πανεπιστημίου Θεσσαλίας, Τμήμα 
Ιατρικής 
                                          MSc Program: 
“Research Methodology in Biomedicine,  
Biostatistics & Clinical Bioinformatics” 
 
                                       Larissa, September 2018 
 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:27:01 EEST - 137.108.70.13
 Contents 
1. Summary         3 
 
2. Introduction        4 
 
 
3. Methods         10 
 
4. Results         11 
 




                                                                                      
 
7. References         16 
 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:27:01 EEST - 137.108.70.13
Περίληψη 
ΣΤΟΧΟΣ: Να γίνει ποιοτική αξιολόγηση μελετών π αρατήρησης σχετικά με την ανταπόκριση 
στη θεραπεία με ιντερφερόνες σε ασθενείς πάσχοντες απο RRMS, από το 2015 ως το 2018, 
χρησιμοποιώντας το STROBE checklist 
Μέθοδοι: Πραγματοποιήθηκε έρευνα στην πλατφόρμα PubMed και επιλέχθηκαν 9 έρευνες 
σχετικές με το θέμα μας δημοσιευμένες μεταξύ 2015 και 2018. Η συμμόρφωση των 
μελετών με τις οδηγίες ποσοτικοποιήθηκε χρησιμοποιώντας ένα σύστημα βαθμολόγησης 
που έδινε 1 βαθμό για κάθε αντικείμενο του ερωτηματολογίου που έπαιρνε την απάντηση 
«ΝΑΙ» και 0 για κάθε «ΟΧΙ». Στη συνέχεια τα άρθρα χωρίστηκαν σε 2 ομάδες ανάλογα με το 
impact factor του περιοδικού όπου δημοσιεύτηκαν και οι μέσες τιμές των βαθμολογιών 
συμμόρφωσης συγκρίθηκαν με ένα t-test για ανεξάρτητα δείγματα. Τέλος τα αποτελέσματα 
συγκρίθηκαν με αυτά μιας παρόμοιας μελέτης που αξιολογούσε την ποιότητα μελετών 
δημοσιευμένων στο Journal of Hand Surgery χρησιμοποιώντας το STROBE checklist 
Aποτελέσματα: Η συνολική συμμόρφωση ήταν 64,6% (95% CI 50%-79%). Οι βαθμοί που 
χάθηκαν ήταν κυρίως αποτέλεσμα της μη αναφοράς στην περίληψη του τύπου της μελέτης 
(55%), μη επισήμανσης πιθανού συστηματικού σφάλματος που μπορεί να υπεισέρχεται στη 
μελέτη(22%), παράλειψης αναφοράς του τρόπου με τον οποίο αποφασίστηκε το μέγεθος 
του δείγματος(0%), και μη παρουσίασης των πηγών χρηματοδότησης. Οι μελέτες που είχαν 
δημοσιευτεί σε περιοδικά με impact factor πάνω από 3 είχαν κατά 6,14 βαθμούς 
υψηλότερη μέση βαθμολογία συμμόρφωσης (p value=0,04, 95%CI 2,8-9,4). H συμμόρφωση 
που παρατηρήθηκε δεν διέφερε στατιστικά σημαντικά από αυτήν που αναφερόταν στη 
μελέτη του Journal of Hand Surgery για την περίοδο του 2016. 
Συμπέρασμα: Η συμμόρφωση με τις κατευθυντήριες οδηγίες STROBE φάνηκε να είναι σε 
καλό επίπεδο, δείχνοντας μια ανοδική τάση στην πάροδο του χρόνου. Η καλύτερη 
συμμόρφωση φαίνεται να σχετίζεται με δημοσίευση σε περιοδικό με καλύτερο impact 
factor. Ωστόσο, φαίνεται να υπάρχει ακόμα χώρος για βελτίωση ειδικά σε ό,τι έχει να κάνει 
με την επισήμανση πιθανού συστηματικού σφάλματος καθώς και με την παρουσίαση του 
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Abstract 
 
PURPOSE: To use the Strengthening The Reporting of Observational studies in Epidemiology 
(STROBE) checklist to evaluate the quality of observational studies regarding the response to 
treatment with interferons in patients with RRMS from 2015 to 2018 
METHODS: PubMed research was conducted and 9 reports of observational studies 
regarding our topic published between 2015 and 2018 were selected. The compliance of the 
reports was quantified using a point system that awarded 1 point for every “YES” in the 
STROBE checklist and 0 for every “NO”. The mean compliance scores were then compared,  
after grouping the reports based on the impact factor of the journal they were published in, 
using independent sample t-test. Ultimately the results were compared to those of a similar 
study assessing the quality of reports published in the Journal of Hand Surgery 
RESULTS: Overall compliance was 64,6% (95% CI 50%-79%). The missing points were a result 
mostly of not indicating the study design in the abstract (55%), not addressing potential bias 
(22%), not mentioning how the size of the sample was arrived at (0%) and not presenting the 
sources of their funding (0%). Reports published in journals with impact factor higher than 3 
were found to have 6,14 points higher compliance score (p value=0,04, 95% CI 2,8-9,4). 
Compliance was found not to differ statistically significantly from that of the 2011 period in 
the Journal of Hand Surgery 
Conclusion: Compliance with the STROBE guidelines seems quite good, showing a rising 
trend through the years. It is evident that better compliance is associated with a publication 
in a journal with higher impact factor. However, there is still room for improvement 
especially as regards addressing sources of potential bias and describing how the size of the 




Much of our knowledge about various medical conditions, risk factors and associations 
between exposures and clinical outcomes comes from observational studies. In this sense, it 
is obvious how critical it is to ensure the high quality of observational studies since they 
provide the basis for understanding the pathophysiological mechanisms underlying medical 
conditions and practice of evidence based medicine. The Strengthening the Reporting of 
Observation Studies in Epidemiology (STROBE) statement was produced in 2007 to “improve 
the quality of observational study reporting, improve transparency in reporting, and allow 
for critical assessment by others of the strengths and weaknesses in study design, conduct, 
and analysis. A team of 23 editors, epidemiologists, methodologists, statisticians, and 
practitioners from Europe and North America created this statement. The STROBE 
statement provides a 22-item checklist of items for inclusion in the reporting of all 
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observational studies including components of the study design, interventions, data 
collection, analytic techniques, and potential bias. Available checklists are specific for each 
of the 3 observational study designs (i.e., cohort, case-control, and cross-sectional). Use of 
these checklists is intended to improve the reader's ability to assess, interpret, and 
generalize study findings. (1) 
MS is a neurological disease affecting an estimated number of 2,500,000 people worldwide 
(2) with important impact on the quality of the life of the patients. Rrms is the most 
common and well-studied form of MS with a lot of research still ongoing. There is already a 
number of approved disease-modifying treatments applied to many patients. Interferons are 
first disease modifying therapy approved by the FDA in 1993. They were shown to decrease 
the frequency of relapses, the MRI lesion burden as well as the disability caused by the 
disease and set the standard to which the later treatments compared. (3) However, despite 
their proven efficacy and safety, the response of the patients is still quite heterogeneous for 
reasons that remain unknown. 
Evaluation of the response to treatment with the means available today in the everyday 
clinical practice such as MRI imaging of new lesions and clinical evaluation (EDSS score), is 
quite accurate, however the time needed for the discrimination of the optimal and 
suboptimal respondents is 1 to 2 years. This time interval is quite critical for the progression 
as initial disease course is regarded as an important prognostic factor, so that non-
respondents have increased risk of facing more relapses and more severe disease course. 
Ideally, we would like to have biomarkers that even before the initiation of the treatment 
would indicate those patients that are expected to respond optimally and those would have 
to seek alternative treatment in order to avoid losing any precious time. That is why studies 
aiming in this direction, investigating the response to the treatment with interferons, were 
chosen to be evaluated for the purposes of this thesis. 
 
 






Title and abstract 1 (a) Indicate the study’s design 
with a commonly used term in 
the title or the abstract 
(b) Provide in the abstract an 
informative and balanced 
summary of what was done and 
what was found 
Introduction 
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Background/rationale 2 Explain the scientific 
background and rationale for 
the investigation being reported 
Objectives 3 State specific objectives, 
including any prespecified 
hypotheses 
Methods 
Study design 4 Present key elements of study 
design early in the paper 
Setting 5 Describe the setting, locations, 
and relevant dates, including 
periods of recruitment, 
exposure, follow-up, and data 
collection 
Participants 6 (a) Cohort study—Give the 
eligibility criteria, and the 
sources and methods of 
selection of participants. 
Describe methods of follow-up 
Case-control study—Give the 
eligibility criteria, and the 
sources and methods of case 
ascertainment and control 
selection. Give the rationale for 
the choice of cases and controls 
Cross-sectional study—Give the 
eligibility criteria, and the 
sources and methods of 
selection of participants 
(b) Cohort study—For matched 
studies, give matching criteria 
and number of exposed and 
unexposed 
Case-control study—For 
matched studies, give matching 
criteria and the number of 
controls per case 
Variables 7 Clearly define all outcomes, 
exposures, predictors, potential 
confounders, and effect 
modifiers. Give diagnostic 
criteria, if applicable 
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Data sources/ measurement 8*  For each variable of interest, 
give sources of data and details 
of methods of assessment 
(measurement). Describe 
comparability of assessment 
methods if there is more than 
one group 
Bias 9 Describe any efforts to address 
potential sources of bias 
Study size 10 Explain how the study size was 
arrived at 
Quantitative variables 11 Explain how quantitative 
variables were handled in the 
analyses. If applicable, describe 
which groupings were chosen 
and why 
Statistical methods 12 (a) Describe all statistical 
methods, including those used 
to control for confounding 
(b) Describe any methods used 
to examine subgroups and 
interactions 
(c) Explain how missing data 
were addressed 
(d) Cohort study—If applicable, 
explain how loss to follow-up 
was addressed 
Case-control study—If 
applicable, explain how 
matching of cases and controls 
was addressed 
Cross-sectional study—If 
applicable, describe analytical 
methods taking account of 
sampling strategy 
(e) Describe any sensitivity 
analyses 
Results 
Participants 13* (a) Report numbers of 
individuals at each stage of 
study—eg numbers potentially 
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eligible, examined for 
eligibility, confirmed eligible, 
included in the study, 
completing follow-up, and 
analysed 
(b) Give reasons for non-
participation at each stage 




14* (a) Give characteristics of study 
participants (eg demographic, 
clinical, social) and information 
on exposures and potential 
confounders 
(b) Indicate number of 
participants with missing data 
for each variable of interest 
(c) Cohort study—Summarise 
follow-up time (eg, average 
and total amount) 
Outcome data 15* Cohort study—Report numbers 
of outcome events or summary 
measures over time 
Case-control study—Report 
numbers in each exposure 
category, or summary 
measures of exposure 
Cross-sectional study—Report 
numbers of outcome events or 
summary measures 
Main results 16 (a) Give unadjusted estimates 
and, if applicable, confounder-
adjusted estimates and their 
precision (eg, 95% confidence 
interval). Make clear which 
confounders were adjusted for 
and why they were included 
(b) Report category boundaries 
when continuous variables 
were categorized 
(c) If relevant, consider 
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translating estimates of 
relative risk into absolute risk 
for a meaningful time period 
Other analyses 17 Report other analyses done—
eg analyses of subgroups and 
interactions, and sensitivity 
analyses 
Discussion 
Key results 18 Summarise key results with 
reference to study objectives 
Limitations 19 Discuss limitations of the study, 
taking into account sources of 
potential bias or imprecision. 
Discuss both direction and 
magnitude of any potential 
bias 
Interpretation 20 Give a cautious overall 
interpretation of results 
considering objectives, 
limitations, multiplicity of 
analyses, results from similar 
studies, and other relevant 
evidence 
Generalisability 21 Discuss the generalisability 
(external validity) of the study 
results 
Other information 
Funding 22 Give the source of funding and 
the role of the funders for the 
present study and, if 
applicable, for the original 
study on which the present 
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Methods 
 
PubMed research was conducted with keywords “rrms”, “interferons” and “response”. The 
publication date filter was set from 2015 to the present day. From the 29 given results 9 
were reports of observational studies and truly relevant to our topic. These 9 articles were 
evaluated using the STROBE checklist. For each item of the checklist answered with “YES” 1 
point was given to the article so that an article that was fully compliant with the STROBE 
guidelines would have a total of 22 points. Some items consisted of more than one bullets 
with each bullet requiring more than one pieces of information. For items like this, the 
approach used was that the point was awarded to the articles that provided most of the 
required information with no significant omissions. This was decided so that no item would 
gain extra impact on the overall score, as would happen if extra points were given for every 
sub-item. The scores were then transformed to compliance rates using the SPSS software. 
The data was passed to Excel sheet so that total score per item and per article could be 
calculated and presented (table 1) 
Then the articles were split into 2 groups based on the impact factor of the journal they 
were published in so that we could investigate if there is an association between that and 
the compliance with the STROBE guidelines. The cutoff point was set to 3 so that the first 
group consisted of articles published in journals with impact factor <3 and the second >3 
Ultimately, the results were compared with those of a similar report of quality evaluation of 
observational trials in the Journal of Hand Surgery. 
Statistical Analysis 
The statistical analysis was conducted using the SPSS software. For the first part, the mean 
values of their score in the strobe checklist of the two groups were compared, using 
independent samples t-test. Normality of the distribution of the data was checked with 
Shapiro-Wilk and Kolmogorov-Smirnov tests. The level of significance was set to 95% (p 
value 5%) 
Comparison with the results of the report in the Journal of Hand Surgery were based on the 
95% CI of the rates of the compliance scores. 
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Overall compliance of the studies evaluated was 64,6% (128 out of 198 max points), 95% CI 
(50%-79%) with range from 31% to 86%. Compliance rate per section can be seen in table 2  
 
Abstract 
The overall compliance of the studies with the STROBE guidelines as regards to the abstract 
was 55%. All the articles presented an informative abstract that summarized the purposes, 
methods, results and conclusions of the study, however only three of them indicated the 
study design with a commonly used term. Given that the first item of the bullet consisted of 
two bullets the one point was awarded to the articles that either covered both bullets or had 
a very well balanced abstract of what was to follow. 
 
 
article 1 2 3 4 5 6 7 8 9 total per item
published in neuroim neuroim neuroim neur sci eur neur neur sci j neurol neuroim neur sci
impact factor 2.959 2.959 2.959 2.353 3.692 2.353 3.470 2.959 2.353
checklist number
abstract 1 0 0 0 1 1 1 0 1 1 5
2 1 1 1 1 1 1 1 1 1 9
3 1 1 1 1 1 1 1 0 1 8
4 1 0 0 1 1 1 1 0 0 5
5 1 0 0 0 1 1 1 1 1 6
6 1 1 1 0 1 1 1 1 1 8
7 1 0 1 0 1 1 1 1 1 7
8 1 1 1 0 1 1 1 1 1 8
9 0 0 0 0 1 0 1 0 0 2
10 0 0 0 0 0 0 0 0 0 0
11 0 1 0 0 1 1 1 1 1 6
12 1 1 1 1 1 1 1 1 1 9
13 1 1 1 1 1 1 1 1 1 9
14 1 0 0 1 1 1 1 1 1 7
15 1 0 0 0 1 1 1 0 0 4
16 1 0 0 0 1 1 1 0 0 4
17 1 0 1 0 0 0 1 0 0 3
18 1 1 1 0 1 1 1 1 1 8
19 0 0 1 0 1 0 1 0 1 4
20 1 1 1 0 1 1 1 1 1 8
21 0 1 0 0 1 1 1 1 1 6
22 0 0 0 0 0 0 0 0 0 0
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Introduction 
 
Introduction was the area with the best compliance  with an overall 94%(17 points out of 18 
total items). The one missing point was due to an article not stating beforehand the 




This area had intermediate compliance with an overall compliance of 61% (51 points out of 
81 total items). This section includes items that require more than one pieces of specific 
information such as item number 5 about Setting, that requires setting, location, relevant 
dates, periods of recruitment, exposure, follow up and data collection. Answering an item 
like this with “yes” or “no” is not that simple as it cannot reflect the amount of the required 
information that was really provided. For items like this the one point was awarded when 
most of the requirements were met and no important detail was left unmentioned. 
The item-by-item compliance was very heterogeneous ranging from 100% for the  statistical 
analysis to 0% for the study size. Another item with very little compliance was number 9 
regarding bias as only 22%(2 out of 9) made an attempt to address potential sources of bias 




The overall compliance of the results section was 60% (27 points out of 45 items) ranging 
from 100% (9 out 9 for item number 13) to 33% (3 out 9 for item number 27). Most studies 
presented enough data regarding the participants (demographics, numbers at each stage, 
follow up, etc.) scoring 16 out of 18 in the first two items. However, they did not report with 
the same consistency outcome data and main results omitting often to present unadjusted 




Discussion section had an overall compliance of 57% (26 points out of 45 items). Ranking of 
this section had a clear pattern as most articles summarized key results and presented a 
cautious approach in the interpretation of the results often mentioning the need for further 
research, scoring a total of 16 out 18 in these two items. However, only 4 of them included 
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in the discussion the existence of potential bias and its sources. Moreover, it is worth 





Comparison Based on Impact factor 
 
 The heterogeneity of the results as it is reflected by the range of the compliance ratios 
(31%-86%) creates the question if there is a factor that can be associated with better 
compliance. It was assumed that publication in a journal with higher impact factor will be 
associated with better compliance ratio and vice versa. In order to test this hypothesis the 
articles were split in two groups based on the impact factor of the journal they were 
published in. The cutoff point was set to 3. The first group consisted of 7 articles published in 
journals with lower than 3 impact factor and the second group had 2 articles published in 
journals with higher than 3 impact factor.  
The comparison was made using the SPSS software. Normality of data was tested with 
Shapiro-Wilk and Kolmogorov-Smirnov tests both showing that it was distributed normally 
(table 3). Then the mean values of the compliance scores of the two groups were compared 
using independent sample t test. Levene’s test does not give statistical significance so we 
continue assuming equal variances. Despite the very limited sample, it was shown that there 
is a statistically significant mean difference in compliance score of the two groups of 6.46 
points, p value=0,04,  95%CI (0,36-12,49). (table 4) These results confirm our initial 
hypothesis 
 
published in neuroim neuroim neuroim neur sci eur neur neur sci j neurol neuroim neur sci Total per
impact factor 2.959 2.959 2.959 2.353 3.692 2.353 3.470 2.959 2.353 Section
Abstract 0% 0% 0% 100% 100% 100% 0% 100% 100% 55%
Introduction 100% 100% 100% 100% 100% 100% 100% 50% 100% 94%
Methods 66% 44% 44% 22% 89% 77% 89% 66% 66% 62%
Results 100% 20% 40% 40% 80% 80% 100% 40% 40% 60%
Discussion 40% 60% 60% 0% 80% 60% 80% 60% 80% 57%
Total per article 68% 45% 50% 31% 86% 77% 86% 59% 68%
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Comparison with similar study 
 
Ultimately seeking external validity to the results we came up with, with the results of 
another STROBE evaluation report regarding studies published in the journal of Hand 
Surgery. This report compared compliance of articles published in two separate 6-month 
periods, one in 2005 and one in 2011. The compliance rates had been found to be 38% (95% 
CI 35%-42%, range 10%-50%) for 2005 and 58% (95% CI 55%-60%, range 39%-85%) 
The 64,6% compliance of our study seems to be in line with the 2011 results as the 
overlapping 95% CI (50%-79%). However, this broad 95% CI that reflects the effect that this 
small sample has on the study, would make it difficult for any statistically significant 
difference to be indicated even if it really exists. 
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Discussion 
 
This study aimed to evaluate the quality of observational reports. The 64,6% rate of 
compliance that was found seems suboptimal. Although there are items that are 
consistently and thoroughly reported in the majority of the articles (scientific background, 
purposes of the study), there is also an important number that are poorly reported (address 
potential sources of bias) or even totally neglected(funding).  
This heterogeneity in the reporting of different items even in the same article reflects the 
different challenges that are met when dealing with each item. Some of them being totally 
theoretical and not creating any conflict seem easy to report. Such an example set the two 
items regarding the introduction which were found to have excellent compliance. However, 
others require much more effort throughout the conduction of the entire study, not just the 
writing the report, in means of data collection and careful information classification, such as 
reporting of events at each stage, describing patient follow up etc. This is reflected on the 
worse compliance rates of the sections methods and results when compared to those of 
introduction, as in these sections the items are much more challenging. Moreover, items like 
number 9 (address bias) may create a conflict of interests as at some point they are 
equivalent to indicate the weakness of one’s own study. So, in addition to the author not 
being aware of any potential bias in their study this would be an extra reason to explain the 
low compliance rates found in this item. 
Lastly, a special mention has to be made to the items that were found to have 0 compliance, 
meaning that not a single article included the information required in those items. Firstly, it 
has to be stated that the rates found in this study are validated by the report in the Journal 
of Hand Surgery, which presented the exact same rates. These two items were about the 
size of the sample and the funding of the study. As regards to the funding, although it may 
illuminate any conflicts of interest that are not apparent and it helps a great deal in the 
transparency of whole process of research, it is not as vital for the report of a study. 
However, the procedure of deciding the sample size has a scientific background based on 
the magnitude of the association that is being investigated and the desirable power of the 
study. What might really be the case here, besides the authors ignoring or neglecting to 
mention how the sample size was decided, is that these studies aimed at a small population 
of patients with a certain disease, under a certain treatment located in certain facilities, so 
they just included all the available patients the could include. 
What is more this study also indicated and association between better compliance rates and 
publication in a journal with higher impact factor. This was a hypothesis assumed be many 
but the fact that it shown in terms of statistical significance despite the very limited size of 
the sample is a potential indicator of size of the magnitude of this association. 
As regards the interpretation of the results, it should be done with great caution. The main 
source of potential bias is the inevitable subjectivity that lies in the scoring of the checklist. 
As mentioned above, some items of the checklist consisted of multiple bullets, each 
requiring multiple pieces of information. Scoring these items was a challenging process that 
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aimed to reward those that provided most information without important omissions. It is 
clear that different reviewers might give different scores, so in the absence of previous 
consensus about it any scoring is subjective. Although the checklist structure facilitates its 
objective scoring and differences between individuals are not expected to be big, the 
presence of subjectivity is not eliminated and must be taken into account as potential source 
of bias. Another problem that must be addressed is the limited size of this study and the 
resulting skewness of the data derived from it. However, the tests of normality in the 
compliance score and statistical method of indicating the differences assure us that it is safe 







The compliance rates found in this study are good but there is certainly room for 
improvement. Taking into account previous studies that show an upward trend through the 
years and the fact that high status journals show better compliance we can conclude that 
reporting of observational studies is heading to the right direction and the quality of future 
studies is expected to be better and better.  
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